3/18
08:17 am
amlx
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) was downgraded by analysts at Mizuho from a "buy" rating to a "neutral" rating.
High
Report
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) was downgraded by analysts at Mizuho from a "buy" rating to a "neutral" rating.
3/18
08:17 am
amlx
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) was downgraded by analysts at Mizuho from a "buy" rating to a "neutral" rating.
High
Report
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) was downgraded by analysts at Mizuho from a "buy" rating to a "neutral" rating.
3/11
11:16 am
amlx
Rating for AMLX
High
Report
Rating for AMLX
3/11
11:16 am
amlx
Rating for AMLX
High
Report
Rating for AMLX
3/11
09:02 am
amlx
Rating for AMLX
High
Report
Rating for AMLX
3/11
09:02 am
amlx
Rating for AMLX
High
Report
Rating for AMLX
3/11
09:02 am
amlx
Rating for AMLX
High
Report
Rating for AMLX
3/11
08:11 am
amlx
Rating for AMLX
High
Report
Rating for AMLX
3/11
08:08 am
amlx
Rating for AMLX
High
Report
Rating for AMLX
3/11
08:08 am
amlx
Rating for AMLX
High
Report
Rating for AMLX
3/11
07:33 am
amlx
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) was downgraded by analysts at Robert W. Baird from an "outperform" rating to a "neutral" rating. They now have a $4.00 price target on the stock, down previously from $37.00.
High
Report
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) was downgraded by analysts at Robert W. Baird from an "outperform" rating to a "neutral" rating. They now have a $4.00 price target on the stock, down previously from $37.00.
1/3
08:08 am
amlx
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $37.00 price target on the stock.
Medium
Report
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $37.00 price target on the stock.
1/3
05:14 am
amlx
Rating for AMLX
Medium
Report
Rating for AMLX
1/3
05:14 am
amlx
Rating for AMLX
Medium
Report
Rating for AMLX